Document is current
Any future updates will be listed below
-
Authors
Nishizaki, Daisuke
Law, Allison
Li, Bailiang
Abbott, Charles
Chen, Yi
Lee, Suzanna
Pyke, Rachel
Keough, Kathleen
Daniels, Gregory A.
Yeung, Kay T.
Boyle, Sean M.
Chen, Richard O.
Kato, Shumei
-
Funding
Funding for this research was provided by:
Personalis, Inc.
- License Information
-
More Information
Article History
Received: 7 October 2025
Accepted: 12 January 2026
First Online: 24 January 2026
Competing interests
: DN, AL, and SL have nothing to disclose. SK serves as a consultant for Aadi Bioscience, Medpace, Foundation Medicine, NeoGenomics and CureMatch. He receives speaker’s fee from Chugai, Roche/Genentech and Bayer, and advisory board for Pfizer. He has research funding from ACT Genomics, Sysmex, Konica Minolta, OmniSeq, Personalis and Function Oncology. KTY receives research funding to their institution from AstraZeneca Pharmaceuticals, Arvinas, Gilead Sciences, Iambic Therapeutics, Jazz Pharmaceuticals, Merck, Pfizer, Relay Therapeutics, and Zymeworks. BL, CWA, YC, RP, KK, SB and RC are employees of Personalis.
